Manning & Napier Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $22.8M | Sell |
820,365
-53,889
| -6% | -$1.5M | 0.26% | 81 |
|
|
2023
Q4 | $25.2M | Sell |
874,254
-152,276
| -15% | -$4.6M | 0.3% | 77 |
|
|
2023
Q3 | $34M | Sell |
1,026,530
-30,419
| -3% | -$1.08M | 0.42% | 64 |
|
|
2023
Q2 | $38.8M | Buy |
1,056,949
+287,261
| +37% | +$11.2M | 0.44% | 63 |
|
|
2023
Q1 | $31.4M | Sell |
769,688
-1,811
| -0.2% | -$78.2K | 0.37% | 71 |
|
|
2022
Q4 | $39.5M | Sell |
771,499
-5,768
| -0.7% | -$277K | 0.49% | 56 |
|
|
2022
Q3 | $34M | Sell |
777,267
-11,859
| -2% | -$576K | 0.44% | 58 |
|
|
2022
Q2 | $41.4M | Buy |
+789,126
| New | +$40.2M | 0.48% | 57 |
|
|
2021
Q2 | – | Sell |
-1,455,218
| Closed | -$52.7M | – | 302 |
|
|
2021
Q1 | $52.7M | Buy |
1,455,218
+30,588
| +2% | +$1.09M | 0.45% | 68 |
|
|
2020
Q4 | $52.4M | Sell |
1,424,630
-158,200
| -10% | -$5.8M | 0.49% | 62 |
|
|
2020
Q3 | $55.1M | Buy |
1,582,830
+10,242
| +0.7% | +$359K | 0.56% | 56 |
|
|
2020
Q2 | $48.8M | Buy |
1,572,588
+26,407
| +2% | +$897K | 0.52% | 60 |
|
|
2020
Q1 | $47.9M | Buy |
1,546,181
+39,007
| +3% | +$1.33M | 0.56% | 56 |
|
|
2019
Q4 | $56M | Buy |
1,507,174
+108,755
| +8% | +$3.87M | 0.6% | 49 |
|
|
2019
Q3 | $47.7M | Buy |
1,398,419
+49,287
| +4% | +$1.79M | 0.53% | 52 |
|
|
2019
Q2 | $55.4M | Buy |
1,349,132
+77,709
| +6% | +$3.09M | 0.6% | 44 |
|
|
2019
Q1 | $51.2M | Buy |
1,271,423
+266,222
| +26% | +$10.7M | 0.56% | 47 |
|
|
2018
Q4 | $41.6M | Buy |
1,005,201
+64,595
| +7% | +$2.68M | 0.51% | 51 |
|
|
2018
Q3 | $39.3M | Buy |
940,606
+55,060
| +6% | +$2.12M | 0.39% | 63 |
|
|
2018
Q2 | $30.5M | Sell |
885,546
-142,713
| -14% | -$4.88M | 0.3% | 70 |
|
|
2018
Q1 | $34.6M | Buy |
1,028,259
+210,360
| +26% | +$7.23M | 0.34% | 66 |
|
|
2017
Q4 | $28.1M | Buy |
+817,899
| New | +$27.9M | 0.25% | 79 |
|
Other funds holding PFE
